Loss of FPGS activity has previously been associated with resistance to the TYMS inhibitor methotrexate in several leukemia cell lines46 and FPGS protein expression is associated with PMX response in malignant pleural mesothelioma47. The gene discussed is FPGS; the disease is leukemia.